Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
Launched by BIOFIRE DIAGNOSTICS, LLC · Sep 3, 2014
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Displays signs and/or symptoms of respiratory infections
- • Adult patients must provide informed consent
- • Parental consent for children (\<18)
- Exclusion Criteria:
- • Adult patients unable to provide informed consent
- • Children that are currently in foster care, or are wards of the state
About Biofire Diagnostics, Llc
BioFire Diagnostics, LLC is a leading molecular diagnostics company dedicated to advancing healthcare through innovative diagnostic solutions. Specializing in rapid and accurate pathogen detection, BioFire develops cutting-edge technologies that enable healthcare providers to make informed decisions quickly. With a commitment to improving patient outcomes, the company’s flagship product, the FilmArray® system, offers comprehensive multiplex testing for infectious diseases, streamlining the diagnostic process in clinical settings. BioFire continuously invests in research and development to expand its product offerings and enhance its position as a trusted partner in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
St. Louis, Missouri, United States
Galveston, Texas, United States
Salt Lake City, Utah, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials